A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo.
Standard
A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo. / Cheng, Qiufang; Tucker, Erik I; Pine, Meghann S; Sisler, India; Matafonov, Anton; Sun, Mao-Fu; White-Adams, Tara C; Smith, Stephanie A; Hanson, Stephen R; McCarty, Owen J T; Renné, Thomas; Gruber, András; Gailani, David.
in: BLOOD, Jahrgang 116, Nr. 19, 19, 2010, S. 3981-3989.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo.
AU - Cheng, Qiufang
AU - Tucker, Erik I
AU - Pine, Meghann S
AU - Sisler, India
AU - Matafonov, Anton
AU - Sun, Mao-Fu
AU - White-Adams, Tara C
AU - Smith, Stephanie A
AU - Hanson, Stephen R
AU - McCarty, Owen J T
AU - Renné, Thomas
AU - Gruber, András
AU - Gailani, David
PY - 2010
Y1 - 2010
N2 - Mice lacking factor XII (fXII) or factor XI (fXI) are resistant to experimentally-induced thrombosis, suggesting fXIIa activation of fXI contributes to thrombus formation in vivo. It is not clear whether this reaction has relevance for thrombosis in pri mates. In 2 carotid artery injury models (FeCl(3) and Rose Bengal/laser), fXII-deficient mice are more resistant to thrombosis than fXI- or factor IX (fIX)-deficient mice, raising the possibility that fXII and fXI function in distinct pathways. Antibody 14E11 binds fXI from a variety of mammals and interferes with fXI activation by fXIIa in vitro. In mice, 14E11 prevented arterial occlusion induced by FeCl(3) to a similar degree to total fXI deficiency. 14E11 also had a modest beneficial effect in a tissue factor-induced pulmonary embolism model, indicating fXI and fXII contribute to thrombus formation even when factor VIIa/tissue factor initiates thrombosis. In baboons, 14E11 reduced platelet-rich thrombus growth in collagen-coated grafts inserted into an arteriovenous shunt. These data support the hypothesis that fXIIa-mediated fXI activation contributes to thrombus formation in rodents and primates. Since fXII deficiency does not impair hemostasis, targeted inhibition of fXI activation by fXIIa may be a useful antithrombotic strategy associated with a low risk of bleeding complications.
AB - Mice lacking factor XII (fXII) or factor XI (fXI) are resistant to experimentally-induced thrombosis, suggesting fXIIa activation of fXI contributes to thrombus formation in vivo. It is not clear whether this reaction has relevance for thrombosis in pri mates. In 2 carotid artery injury models (FeCl(3) and Rose Bengal/laser), fXII-deficient mice are more resistant to thrombosis than fXI- or factor IX (fIX)-deficient mice, raising the possibility that fXII and fXI function in distinct pathways. Antibody 14E11 binds fXI from a variety of mammals and interferes with fXI activation by fXIIa in vitro. In mice, 14E11 prevented arterial occlusion induced by FeCl(3) to a similar degree to total fXI deficiency. 14E11 also had a modest beneficial effect in a tissue factor-induced pulmonary embolism model, indicating fXI and fXII contribute to thrombus formation even when factor VIIa/tissue factor initiates thrombosis. In baboons, 14E11 reduced platelet-rich thrombus growth in collagen-coated grafts inserted into an arteriovenous shunt. These data support the hypothesis that fXIIa-mediated fXI activation contributes to thrombus formation in rodents and primates. Since fXII deficiency does not impair hemostasis, targeted inhibition of fXI activation by fXIIa may be a useful antithrombotic strategy associated with a low risk of bleeding complications.
KW - Animals
KW - Humans
KW - Male
KW - Disease Models, Animal
KW - Mice
KW - Mice, Inbred BALB C
KW - Mice, Knockout
KW - Dogs
KW - Rabbits
KW - Species Specificity
KW - Antibodies, Monoclonal/pharmacology
KW - Cats
KW - Factor XIIa/physiology
KW - Anticoagulants/pharmacology
KW - Carotid Artery Thrombosis/blood/etiology
KW - Factor XI/antagonists & inhibitors/physiology
KW - Factor XI Deficiency/blood/genetics/physiopathology
KW - Factor XII Deficiency/blood/genetics/physiopathology
KW - Papio anubis
KW - Partial Thromboplastin Time
KW - Pulmonary Embolism/blood/etiology
KW - Thrombosis/blood/etiology
KW - Animals
KW - Humans
KW - Male
KW - Disease Models, Animal
KW - Mice
KW - Mice, Inbred BALB C
KW - Mice, Knockout
KW - Dogs
KW - Rabbits
KW - Species Specificity
KW - Antibodies, Monoclonal/pharmacology
KW - Cats
KW - Factor XIIa/physiology
KW - Anticoagulants/pharmacology
KW - Carotid Artery Thrombosis/blood/etiology
KW - Factor XI/antagonists & inhibitors/physiology
KW - Factor XI Deficiency/blood/genetics/physiopathology
KW - Factor XII Deficiency/blood/genetics/physiopathology
KW - Papio anubis
KW - Partial Thromboplastin Time
KW - Pulmonary Embolism/blood/etiology
KW - Thrombosis/blood/etiology
M3 - SCORING: Journal article
VL - 116
SP - 3981
EP - 3989
JO - BLOOD
JF - BLOOD
SN - 0006-4971
IS - 19
M1 - 19
ER -